share_log

OUE Healthcare Warns of H1 2024 Loss

OUE Healthcare Warns of H1 2024 Loss

華聯醫療警告2024年上半年將會虧損。
Singapore Business Review ·  07/28 22:26

One reason for the loss is the disposal of vacant land in Kuala Lumpur.

損失的原因之一是處置吉隆坡的空置土地。

OUE Healthcare expects a loss attributable to shareholders in H1 2024.

OUE Healthcare預計,2024年上半年股東將出現虧損。

In a bourse filing, the company attributed its expected net loss to its one-off loss arising from the disposal of the vacant land in Kuala Lumpur, amongst others.

在證券交易所的文件中,該公司將其預期的淨虧損歸因於處置吉隆坡空地所產生的一次性虧損等。

Startup costs and operating losses from its hospitals in China, the foreign exchange impact of a strong Singapore dollar, and higher financing costs from loans taken to fund the 2023 acquisition of Healthway Medical Corporation Limited's shares also affected the company's bottom line, according to their statement.

他們的聲明稱,其在中國醫院的啓動成本和運營損失、新加坡元堅挺的外匯影響,以及爲2023年收購Healthway Medical Corporation Limited股票提供資金而獲得的貸款所產生的更高融資成本也影響了該公司的利潤。

The company is finalising its unaudited financial results for the period and will release it on or before 14 August.

該公司正在敲定該期間未經審計的財務業績,並將於8月14日當天或之前發佈。

In the meantime, the company advised its shareholders and potential investors to exercise caution when dealing with its shares.

同時,該公司建議其股東和潛在投資者在處理股票時要謹慎行事。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論